Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study

Lancet Diabetes and Endocrinology,The - Tập 2 - Trang 289-297 - 2014
Richard E Pratley1, Michael A Nauck2, Anthony H Barnett3, Mark N Feinglos4, Fernando Ovalle5, Illana Harman-Boehm6, June Ye7, Rhona Scott8, Susan Johnson7, Murray Stewart9, Julio Rosenstock10
1Florida Hospital Diabetes and Translational Research Institute, Sanford-Burnham Medical Research Institute, Orlando, FL, USA
2Diabeteszentrum Bad Lauterberg, Harz, Germany
3Birmingham Heartlands Hospital, Birmingham, UK
4Duke University, Durham, NC, USA
5University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
6Ben-Gurion University of the Negev, Beer Sheva, Israel
7GlaxoSmithKline, Research Triangle Park, NC, USA
8GlaxoSmithKline, Stevenage, Hertfordshire, UK
9GlaxoSmithKline, Upper Merion, PA, USA
10Dallas Diabetes and Endocrine Center, Dallas, TX, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Lancet Diabetes and Endocrinology,The

Tập 2

289-297

Thông tin tác giả